Position in LH
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$1,600
+$95 QoQ
Shares Held
6
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026ALBION FINANCIAL GROUP /UT holds $13,117,631 across 9 Diagnostics & Research names. LH ranks #7 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
24,328 | $11,957,941 | |
| 2 | A |
Agilent Technologies, Inc.
|
7,826 | $892,007 | |
| 3 | DHR |
Danaher Corp /De/
|
1,290 | $244,584 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
26 | $14,609 | |
| 5 | WAT |
Waters Corp /De/
|
15 | $4,467 | |
| 6 | DGX |
Quest Diagnostics Inc
|
11 | $2,155 | |
| 7 | LH |
Labcorp Holdings Inc.
This page
|
6 | $1,600 | |
| 8 | ILMN |
Illumina, Inc.
|
2 | $246 |
All Filings in LH
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,600 | 6 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $1,505 | 6 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $1,722 | 6 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $1,575 | 6 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $1,396 | 6 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $1,375 | 6 | Shares | Sole | 2025-01-17 | |
| No filing history on record for this holder in this stock. | ||||||